Goat anti-cytokeratin 19 (aa285-298), Biotinylated Antibody

Goat anti-cytokeratin 19 (aa285-298), Biotinylated Antibody
Principle Name: cytokeratin 19 (aa285-298), Biotinylated
Official Symbol: KRT19
All Name and Symbols: KRT19; keratin 19, type I; CK19; K19; K1CS; 40-kDa keratin intermediate filament; CK-19; cytokeratin 19; cytokeratin-19; keratin, type I, 40-kd; keratin-19
Accession Number(s): NP_002267.2
Peptide Sequence: HTEQLQMSRSEVTD., is from internal region
Human Gene ID(s): 3880
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Supplied As: lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20C. Minimize freezing and thawing.
Applications: Pep ELISA, WB, EIA
Peptide ELISA: antibody detection limit dilution 1 to 128000.
Western Blot: Approx 45kDa band observed in Human Colorectal cancer lysates (calculated MW of 44.1kDa according to NP_002267.2). See non-biotinylated parental product's datasheet for further QC data. Recommended concentration: 0.3-1ug/ml.
Reference(s): Alix-Panabieres C, Vendrell JP, Slijper M, Pelle O, Barbotte E, Mercier G, Jacot W, Fabbro M, Pantel K. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast cancer research : BCR 2009 11 (3): R39.PMID: 19549321